PL357179A1 - Stosowanie kwasu 2-metylotiazolidyno-2,4-dikarboksylowego (2-MTDC) i/lub jego fizjologicznie dopuszczalnych soli jako środka przeciwnowotworowego - Google Patents

Stosowanie kwasu 2-metylotiazolidyno-2,4-dikarboksylowego (2-MTDC) i/lub jego fizjologicznie dopuszczalnych soli jako środka przeciwnowotworowego

Info

Publication number
PL357179A1
PL357179A1 PL01357179A PL35717901A PL357179A1 PL 357179 A1 PL357179 A1 PL 357179A1 PL 01357179 A PL01357179 A PL 01357179A PL 35717901 A PL35717901 A PL 35717901A PL 357179 A1 PL357179 A1 PL 357179A1
Authority
PL
Poland
Prior art keywords
mtdc
methyl
dicarboxylic acid
thiazolidin
treating
Prior art date
Application number
PL01357179A
Other languages
English (en)
Inventor
Rudy Susilo
Original Assignee
Rudy Susilo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rudy Susilo filed Critical Rudy Susilo
Publication of PL357179A1 publication Critical patent/PL357179A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL01357179A 2000-02-15 2001-02-15 Stosowanie kwasu 2-metylotiazolidyno-2,4-dikarboksylowego (2-MTDC) i/lub jego fizjologicznie dopuszczalnych soli jako środka przeciwnowotworowego PL357179A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008159A DE10008159B4 (de) 2000-02-15 2000-02-15 Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel
PCT/DE2001/000656 WO2001060343A2 (de) 2000-02-15 2001-02-15 Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen

Publications (1)

Publication Number Publication Date
PL357179A1 true PL357179A1 (pl) 2004-07-26

Family

ID=7631906

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01357179A PL357179A1 (pl) 2000-02-15 2001-02-15 Stosowanie kwasu 2-metylotiazolidyno-2,4-dikarboksylowego (2-MTDC) i/lub jego fizjologicznie dopuszczalnych soli jako środka przeciwnowotworowego

Country Status (15)

Country Link
US (2) US6943185B2 (pl)
EP (1) EP1255538B1 (pl)
JP (1) JP2003522782A (pl)
CN (1) CN1400899A (pl)
AT (1) ATE252383T1 (pl)
AU (1) AU783933B2 (pl)
CA (1) CA2399709C (pl)
DE (2) DE10008159B4 (pl)
EA (1) EA004592B1 (pl)
ES (1) ES2208571T3 (pl)
MX (1) MXPA02007903A (pl)
PL (1) PL357179A1 (pl)
PT (1) PT1255538E (pl)
TR (1) TR200302134T4 (pl)
WO (1) WO2001060343A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050197406A1 (en) * 1999-04-14 2005-09-08 Li Chiang J. Method of treatment of lung cancer
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel
NZ531890A (en) * 2002-02-28 2006-02-24 Japan Tobacco Inc Ester compound and medicinal use thereof
EP1669345A4 (en) * 2003-08-29 2008-02-20 Japan Tobacco Inc ESTER DERIVATIVE AND MEDICAL USE THEREOF
DE102004021658A1 (de) * 2004-05-03 2005-12-01 Rudy Dr. Susilo Kombinationspräparate enthaltend 2-Methylthiazolidin-2,4-dicarbonsäure
US20060030623A1 (en) * 2004-07-16 2006-02-09 Noboru Furukawa Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
US8101774B2 (en) * 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
KR20070072888A (ko) * 2004-10-25 2007-07-06 니뽄 다바코 산교 가부시키가이샤 용해성 및 안정성이 개선된 고형 제제 및 그의 제조 방법
JP5439849B2 (ja) * 2008-02-28 2014-03-12 味の素株式会社 システイン誘導体
JP5378713B2 (ja) * 2008-06-19 2013-12-25 日本理化学薬品株式会社 外用組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19711052C2 (de) * 1997-03-03 1999-09-23 Hans Rommelspacher Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure als Mukolytikum
DE19711053C2 (de) * 1997-03-03 1999-09-02 Rommelspacher Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel

Also Published As

Publication number Publication date
WO2001060343A2 (de) 2001-08-23
DE10008159A1 (de) 2001-09-06
EA200200853A1 (ru) 2003-02-27
US20050187271A1 (en) 2005-08-25
US6943185B2 (en) 2005-09-13
JP2003522782A (ja) 2003-07-29
ES2208571T3 (es) 2004-06-16
WO2001060343A3 (de) 2002-05-30
ATE252383T1 (de) 2003-11-15
MXPA02007903A (es) 2004-09-10
CA2399709A1 (en) 2001-08-23
DE10008159B4 (de) 2005-08-18
AU3919001A (en) 2001-08-27
DE50100833D1 (de) 2003-11-27
EP1255538A2 (de) 2002-11-13
US20030149085A1 (en) 2003-08-07
PT1255538E (pt) 2004-03-31
EA004592B1 (ru) 2004-06-24
CA2399709C (en) 2007-05-15
TR200302134T4 (tr) 2004-01-21
EP1255538B1 (de) 2003-10-22
AU783933B2 (en) 2005-12-22
CN1400899A (zh) 2003-03-05

Similar Documents

Publication Publication Date Title
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
WO2002076499A3 (en) Combination treatment of pancreatic cancer
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
GEP20063934B (en) Methods of treatment of a bcl-2 disorder
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
AU6048201A (en) Quinazoline derivatives for the treatment of tumours
HK1050860A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
MY138883A (en) Use of asiatic acid for treatment of cencer
MXPA03003632A (es) Metodo para tratamiento de tumores usando terapia de combinacion.
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
AU2001260880A1 (en) Pharmaceutical compounds for treating copd
MXPA03008582A (es) Agentes y metodos para tratamiento de cancer.
AU2001245295A1 (en) Methods and compositions for the identification, assessment, prevention and therapy of human cancers
PL357179A1 (pl) Stosowanie kwasu 2-metylotiazolidyno-2,4-dikarboksylowego (2-MTDC) i/lub jego fizjologicznie dopuszczalnych soli jako środka przeciwnowotworowego
GB0020504D0 (en) Therapeutic method
AU2001238493A1 (en) Methods and compositions for the identification, assessment, prevention and therapy of human cancers
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
HK1079116A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
ZA200004363B (en) Treatment or prevention of coccidiosis.
MXPA02012209A (es) Terapia combinada contra tumores que comprende derivados de bistamicina acriloilo substituida y agentes de alquilacion.
ZA200203166B (en) Treatment of cancer.
WO2000037065A3 (en) Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs
ZA200209835B (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or anti-metabolites.
AU2001245939A1 (en) Compositions and methods for the identification, assessment, prevention, and therapy of human cancers

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)